A Swedish National Register-Based Assessment for the factors associated with the use of Remicade and biosimilars
Latest Information Update: 25 Jan 2017
At a glance
- Drugs Infliximab (Primary) ; Infliximab (Primary)
- Indications Rheumatic disorders
- Focus Therapeutic Use
- 25 Jan 2017 New trial record